Sertraline Hydrochloride from Canada
Sertraline hydrochloride is a selective serotonin reuptake inhibitor (SSRI) used primarily as an antidepressant for treating major depressive disorder and anxiety disorders. As an aromatic monoamine derivative with amine-function characteristics, it falls under HTS 2921.49.38.00 specifically for psychotherapeutic agents.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.6093.5%Pharmaceuticals: patented pharma articles — 100% floor rate
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Require FDA approval and Drug Master File (DMF) submission for active pharmaceutical ingredients (APIs)
• Ensure Certificate of Analysis (CoA) verifies purity >99% and absence of impurities per USP standards
• Avoid misclassification as general aromatic amines; specify psychotherapeutic end-use in documentation